Potential role of a membrane-bound NADH oxidoreductase in nitric oxide release and arterial relaxation to nitroprusside

Circulation Research

Volumn 84, Issue 2, 1999, Pages 220-228

  Mohazzab H , Kamal M ^a   Kaminski, Pawel M ^a   Agarwal, Ritu ^a   Wolin, Michael S ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Electron transport; Guanylate cyclase; Nitric oxide; Nitroprusside; Redox

Indexed keywords

FERRICYANIDE; FLAVOPROTEIN; GLYCERYL TRINITRATE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; OXIDOREDUCTASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; TETRAZOLIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATALYSIS; CATTLE; DRUG METABOLISM; ELECTRON TRANSPORT; ENZYME ACTIVITY; ENZYME BINDING; ENZYME RELEASE; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PULMONARY ARTERY; VASCULAR SMOOTH MUSCLE; VASODILATATION;

EID: 0033524687     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.84.2.220     Document Type: Article

References (29)

1. Kreye VA, Reske SN. Possible site of the in vivo disposition of sodium nitroprusside in the rat. Naunyn Schmiedebergs Arch Pharmacol. 1982; 320:260-265.
2. Bates JN, Baker MT, Guerra R, Harrison DG. Nitric oxide generation from nitroprusside by vascular tissue: evidence that reduction of the nitroprusside anion and cyanide loss are required. Biochem Pharmacol. 1991;42(suppl):S157-S165.
3. Murad F. Cyclic guanosine monophosphate as a mediator of vasodilation. J Clin Invest. 1986;78:1-5.
4. Ignarro LJ. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res. 1989; 65:1-21.
5. Bates JN, Harrison DG. The nitrovasodilators: new ideas about old drugs. Circulation. 1993;87:1461-1467.
6. Keith RA, Burkman AM, Sokoliski TD, Fertel RH. Vascular tolerance to nitroglycerin and cyclic GMP generation in rat aortic smooth muscle. J Pharmacol Exp Ther. 1982;221:525-531.
7. Ignarro LJ, Lippton H, Edwards JC, Baricos WH, Hyman AL, Kadowitz PJ, Gruetter CA. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther. 1981;218:739-749.
8. Kowaluk EA, Seth P, Fung H-L. Metabolic activation of sodium nitroprusside to nitric oxide in vascular tissue. J Pharmacol Exp Ther. 1992; 262:916-922.
9. Rao DN, Elguindi S, O'Brien PJ. Reductive metabolism of nitroprusside in rat hepatocytes and human erythrocytes. Arch Biochem Biophys. 1991; 286:30-37.
10. Rao DN, Cederbaum AI. Production of nitric oxide and other iron-containing metabolites during the reductive metabolism of nitroprusside by microsomes and by thiols. Arch Biochem Biophys. 1995;321:363-371.
11. Chung SJ, Fung HL. Identification of the subcellular site for nitroglycerin metabolism to nitric oxide in bovine coronary artery smooth muscle cells. J Pharmacol Exp Ther. 1990;253:614-619.
12. Yuan R, Sumi M, Benet LZ. Investigation of aortic CYP3A biotransformation of nitroglycerin in vivo. J Pharmacol Exp Ther. 1997;281: 1499-1505.
13. Mohazzab-H KM, Gurrant C, Wolin MS. Microsomal NADH-oxidoreductase mediates nitric oxide release and relaxation to nitroprusside in the calf pulmonary artery. Circulation. 1992;86(suppl I):I-489. Abstract.
14. Mohazzab-H KM, Wolin MS. Sites of superoxide anion production in calf pulmonary arterial smooth muscle. Am J Physiol. 1994;267: L815-L822.
15. 2 sensor. Am J Physiol. 1994;267:L823-L831.
16. 2-elicited responses. Am J Physiol. 1995;269: L637-L644.
17. 2 and cGMP. Am J Physiol. 1993;264:L141-L145.
18. Marks GS, McLaughlin BE, Brown LB, Beaton DE, Booth BP, Nakatsu K, Brien JF. Interaction of glyceryl trinitrate and sodium nitroprusside with bovine pulmonary artery vein homogenate and 10,000Xg supernatant: biotransformation and nitric oxide formation. Can J Physiol Pharmacol. 1991;69:889-892.
19. Marks GS, McLaughlin BE, Jimmo SL, Poklewska-Koziell M, Brien JF, Nakatsu K. Time-dependent increase in nitric oxide formation concurrent with vasodilation induced by sodium nitroprusside, 3-morpholinosydnonimine, and S-nitroso-N-acetylpenicillamine but not by glyceryl trinitrate. Drug Metab Dispos. 1995;23:1248-1252.
20. Wu M, Pritchard KA, Kaminski PM, Fayngersh RP, Hintze TH, Wolin MS. Involvement of nitric oxide and nitrosothiols in relaxation of pulmonary arteries to peroxynitrite. Am J Physiol. 1994;266:H2108-H2113.
21. Murphy ME, Piper HM, Watanabe H, Sies H. Nitric oxide production by cultured aortic endothelial cells in response to thiol depletion and replenishment. J Biol Chem. 1991;266:19378-19383.
22. Trudgill P. Oxygen consumption. In: Greenwald RA, ed. Handbook of Methods for Oxygen Radicals Research. Boca Raton, Fla: CRC Press; 1986:329-342.
23. Peiper GM, Siebeneich W. The use of a nitronyl nitroxide to discriminate the contribution of nitric oxide radical in endothelium-dependent relaxation of control and diabetic blood vessels. J Pharmacol Exp Ther. 1997;283:138-147.
24. Brunner F, Schmidt K, Neilsen EB, Mayer B. Novel guanylyl cyclase inhibitor potently inhibits potently inhibits cyclic GMP accumulation in endothelial cells and relaxation of bovine pulmonary artery. J Pharmacol Exp Ther. 1996;277:48-53.
25. Edwards JC, Ignarro LJ, Hyman AL, Kadowitz PJ. Relaxation of intrapulmonary artery and vein by nitrogen oxide-containing vasodilators. J Pharmacol Exp Ther. 1984;228:33-42.
26. O'Donnell VB, Smith GCM, Jones OTG. Involvement of phenyl radicals in iodonium compound inhibition of flavoprotein enzymes. Mol Pharmacol. 1994;46:778-785.
27. Crane FL, Sun IL, Clark MG, Grebing C, Low H. Transplasmamembrane redox systems in growth and development. Biochim Biophys Acta. 1985;811:233-264.
28. Medina MA, del Castillo-Ilivares A, Nunez de Castro I. Multifunctional plasma membrane redox systems. BioEssays. 1997;19:977-984.
29. Asano Y, Koehler RC, Ulatowski JA, Traystman RJ, Bucci E. Effect of cross-linked hemoglobin transfusion on endothelial-dependent dilation in cat pial arterioles. Am J Physiol. 1998;275:H1313-H1321.